Patents by Inventor Stephen L. Crooks

Stephen L. Crooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200110006
    Abstract: A desorber for a trace detection system. The desorber includes an inlet configured to receive a sample, a heating element configured to generate a vapor from the sample, and an active cooling element configured to cool the desorber.
    Type: Application
    Filed: September 20, 2019
    Publication date: April 9, 2020
    Inventors: Bradley Douglas Shaw, Dung Lu, Stephen L. Crook, Karl Goedecke, Hanh T. Lai, Vladimir Romanov
  • Patent number: 10458885
    Abstract: A desorber for a trace detection system. The desorber includes an inlet configured to receive a sample, a heating element configured to generate a vapor from the sample, and an active cooling element configured to cool the desorber.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: October 29, 2019
    Assignee: Rapiscan Systems, Inc.
    Inventors: Bradley Douglas Shaw, Dung Lu, Stephen L. Crook, Karl Goedecke, Hanh T. Lai, Vladimir Romanov
  • Publication number: 20180284081
    Abstract: A desorber for a trace detection system. The desorber includes an inlet configured to receive a sample, a heating element configured to generate a vapor from the sample, and an active cooling element configured to cool the desorber.
    Type: Application
    Filed: March 31, 2017
    Publication date: October 4, 2018
    Inventors: Bradley Douglas Shaw, Dung Lu, Stephen L. Crook, Karl Goedecke, Hanh T. Lai, Vladimir Romanov
  • Patent number: 7880137
    Abstract: Apparatuses and method are provided. For example, in one embodiment, a ring electrode includes a plurality of sub-rings adapted to provide an electric field inside a spectrometer. The sub-rings have an internal sub-ring radius. There is a ring insulator between adjacent sub-rings. Each said ring insulator has substantially the same internal radius as the sub-rings. In another embodiment, a method is provided for insertion of the ring electrode inside the spectrometer.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: February 1, 2011
    Assignee: Morpho Detection, Inc.
    Inventors: William J. McGann, Stephen L. Crook
  • Patent number: 7678918
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
    Type: Grant
    Filed: December 6, 2007
    Date of Patent: March 16, 2010
    Assignees: 3M Innovative Properties Company, Graceway Pharmaceuticals, LLC
    Inventors: John F. Gerster, Kyle J. Lindstrom, Stephen L. Crooks, Philip D. Heppner, Gregory J. Marszalek, Peter V. Maye, Bryon A. Merrill, John W. Mickelson, Michael J. Rice
  • Publication number: 20090166521
    Abstract: Apparatuses and method are provided. For example, in one embodiment, a ring electrode includes a plurality of sub-rings adapted to provide an electric field inside a spectrometer. The sub-rings have an internal sub-ring radius. There is a ring insulator between adjacent sub-rings. Each said ring insulator has substantially the same internal radius as the sub-rings. In another embodiment, a method is provided for insertion of the ring electrode inside the spectrometer.
    Type: Application
    Filed: December 28, 2007
    Publication date: July 2, 2009
    Inventors: William J. McGann, Stephen L. Crook
  • Publication number: 20090023722
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Application
    Filed: June 30, 2008
    Publication date: January 22, 2009
    Inventors: Patrick L. Coleman, Stephen L. Crooks, George W. Griesgraber, Kyle J. Lindstrom, Bryon A. Merrill, Michael J. Rice
  • Publication number: 20080306252
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and sulfonamide or sulfamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Application
    Filed: May 30, 2008
    Publication date: December 11, 2008
    Applicant: Coley Pharmaceutical Group, Inc.
    Inventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill, Ralph R. Roberts, Ai-Ping Wei
  • Patent number: 7393859
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: July 1, 2008
    Assignee: Coley Pharmaceutical Group, Inc.
    Inventors: Patrick L. Coleman, Stephen L. Crooks, George W. Griesgraber, Kyle J. Lindstrom, Bryon A. Merrill, Michael J. Rice
  • Patent number: 7335773
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
    Type: Grant
    Filed: February 13, 2006
    Date of Patent: February 26, 2008
    Assignee: Graceway Pharmaceuticals, LLC
    Inventors: John F. Gerster, Kyle J. Lindstrom, Stephen L. Crooks, Philip D. Heppner, Gregory J. Marszalek, Peter V. Maye, Bryon A. Merrill, John W. Mickelson, Michael J. Rice
  • Patent number: 7157453
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: January 20, 2005
    Date of Patent: January 2, 2007
    Assignee: 3M Innovation Properties Company
    Inventors: Stephen L. Crooks, Michael J. Rice
  • Patent number: 7115622
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and amide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: February 28, 2005
    Date of Patent: October 3, 2006
    Assignee: 3M Innovative Properties Company
    Inventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill
  • Patent number: 7078523
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and urea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: October 7, 2003
    Date of Patent: July 18, 2006
    Assignee: 3M Innovative Properties Company
    Inventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill
  • Patent number: 7049439
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain ether and urea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: October 7, 2003
    Date of Patent: May 23, 2006
    Assignee: 3M Innovative Properties Co.
    Inventors: Stephen L. Crooks, George W. Griesgraber, Philip D. Heppner, Bryon A. Merrill
  • Patent number: 7038051
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Grant
    Filed: July 25, 2005
    Date of Patent: May 2, 2006
    Assignee: 3M Innovative Properties Company
    Inventors: John F. Gerster, Kyle J. Lindstrom, Stephen L. Crooks, Philip D. Heppner, Gregory J. Marszalek, Peter V. Maye, Bryon A. Merrill, John W. Mickelson, Michael J. Rice
  • Patent number: 7030131
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: April 18, 2006
    Inventors: Stephen L. Crooks, Bryon A. Merrill
  • Patent number: 6949646
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: September 27, 2005
    Assignee: 3M Innovative Properties Co.
    Inventors: John F. Gerster, Kyle J. Lindstrom, Stephen L. Crooks, Philip D. Heppner, Gregory J. Marszalek, Peter V. Maye, Bryon A. Merrill, John W. Mickelson, Michael J. Rice
  • Patent number: 6897221
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain urea, thiourea, acylurea, or sulfonylurea functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: February 17, 2004
    Date of Patent: May 24, 2005
    Assignee: 3M Innovative Properties Company
    Inventors: Stephen L. Crooks, Michael J. Rice
  • Patent number: 6894165
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Grant
    Filed: April 14, 2004
    Date of Patent: May 17, 2005
    Assignee: 3M Innovative Properties Company
    Inventors: John F. Gerster, Kyle J. Lindstrom, Stephen L. Crooks, Philip D. Heppner, Gregory J. Marszalek, Peter V. Maye, Bryon A. Merrill, John W. Mickelson, Michael J. Rice
  • Patent number: 6888000
    Abstract: Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain sulfonamide or sulfonamide functionality at the 1-position are useful as immune response modifiers. The compounds and compositions of the invention can induce the biosynthesis of various cytokines and are useful in the treatment of a variety of conditions including viral diseases and neoplastic diseases.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: May 3, 2005
    Assignee: 3M Innovative Properties Company
    Inventors: Stephen L. Crooks, George W. Griesgraber, Kyle J. Lindstrom, Bryon A. Merrill, Michael J. Rice